Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges

The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied health economics and health policy 2024-11, Vol.22 (6), p.797-804
Hauptverfasser: Espinosa, Oscar, Rodríguez-Lesmes, Paul, Romano, Giancarlo, Orozco, Esteban, Basto, Sergio, Ávila, Diego, Mesa, Lorena, Enríquez, Hernán
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 804
container_issue 6
container_start_page 797
container_title Applied health economics and health policy
container_volume 22
creator Espinosa, Oscar
Rodríguez-Lesmes, Paul
Romano, Giancarlo
Orozco, Esteban
Basto, Sergio
Ávila, Diego
Mesa, Lorena
Enríquez, Hernán
description The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.
doi_str_mv 10.1007/s40258-024-00900-5
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11470905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3079172397</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-41d1d428935e8edb4c0a58c45a82662e47bd53c486ed7b6b52d0ff1b098193073</originalsourceid><addsrcrecordid>eNp9UU1v3SAQRFGjJk37B3KokHrphQYw2NBLFT2lTaVIfYfk0BPCsH52xDMp2JHy74vz0nwdemGRdnZmdgehY0a_MEqbkywol4pQLgilmlIi99AhY40mTOn6zf1fEllLfoDe5XxNKa9rLd6ig0ppLYXmh-j3VQYcO7yKeSJnXQduGm5hhJzxZZ8g9zH4jIcRn4MNU-9sArye2zA4vI7lvfuK1ylu0jJgR49XvQ0Bxg3k92i_syHDh4d6hK6-n12uzsnFrx8_V6cXxBUXExHMMy-40pUEBb4VjlqpnJBWFbccRNN6WTmhavBNW7eSe9p1rKVaMV3RpjpC33a8N3O7Be9gnJIN5iYNW5vuTLSDedkZh95s4q1hTDTlbLIwfH5gSPHPDHky2yE7CMGOEOdsiopmDa_0IvbpFfQ6zmks-5mKMaXkskhB8R3KpZhzgu7RDaNmic7sojMlOnMfnVlcfHy-x-PIv6wKoNoBcmmVC6cn7f_Q_gV5WqRP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3118852893</pqid></control><display><type>article</type><title>Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges</title><source>MEDLINE</source><source>PAIS Index</source><source>SpringerNature Journals</source><creator>Espinosa, Oscar ; Rodríguez-Lesmes, Paul ; Romano, Giancarlo ; Orozco, Esteban ; Basto, Sergio ; Ávila, Diego ; Mesa, Lorena ; Enríquez, Hernán</creator><creatorcontrib>Espinosa, Oscar ; Rodríguez-Lesmes, Paul ; Romano, Giancarlo ; Orozco, Esteban ; Basto, Sergio ; Ávila, Diego ; Mesa, Lorena ; Enríquez, Hernán</creatorcontrib><description>The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.</description><identifier>ISSN: 1175-5652</identifier><identifier>ISSN: 1179-1896</identifier><identifier>EISSN: 1179-1896</identifier><identifier>DOI: 10.1007/s40258-024-00900-5</identifier><identifier>PMID: 38995492</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Clinical decision making ; Clinical outcomes ; Comparative analysis ; Cost analysis ; Cost-Benefit Analysis ; Costs ; Decision making ; Effectiveness ; GDP ; Gross Domestic Product ; Health Administration ; Health care expenditures ; Health care policy ; Health disparities ; Health Economics ; Health policy ; Health Policy - economics ; Health technology assessment ; Humans ; Medicine ; Medicine &amp; Public Health ; Opportunity costs ; Pharmacoeconomics and Health Outcomes ; Policy Making ; Price regulations ; Pricing policies ; Public Health ; Public Policy ; Quality of Life Research ; Review ; Review Article ; Thailand</subject><ispartof>Applied health economics and health policy, 2024-11, Vol.22 (6), p.797-804</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>Copyright Springer Nature B.V. Nov 2024</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c389t-41d1d428935e8edb4c0a58c45a82662e47bd53c486ed7b6b52d0ff1b098193073</cites><orcidid>0000-0003-4893-0509 ; 0000-0003-1058-3062</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40258-024-00900-5$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40258-024-00900-5$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27866,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38995492$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Espinosa, Oscar</creatorcontrib><creatorcontrib>Rodríguez-Lesmes, Paul</creatorcontrib><creatorcontrib>Romano, Giancarlo</creatorcontrib><creatorcontrib>Orozco, Esteban</creatorcontrib><creatorcontrib>Basto, Sergio</creatorcontrib><creatorcontrib>Ávila, Diego</creatorcontrib><creatorcontrib>Mesa, Lorena</creatorcontrib><creatorcontrib>Enríquez, Hernán</creatorcontrib><title>Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges</title><title>Applied health economics and health policy</title><addtitle>Appl Health Econ Health Policy</addtitle><addtitle>Appl Health Econ Health Policy</addtitle><description>The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.</description><subject>Clinical decision making</subject><subject>Clinical outcomes</subject><subject>Comparative analysis</subject><subject>Cost analysis</subject><subject>Cost-Benefit Analysis</subject><subject>Costs</subject><subject>Decision making</subject><subject>Effectiveness</subject><subject>GDP</subject><subject>Gross Domestic Product</subject><subject>Health Administration</subject><subject>Health care expenditures</subject><subject>Health care policy</subject><subject>Health disparities</subject><subject>Health Economics</subject><subject>Health policy</subject><subject>Health Policy - economics</subject><subject>Health technology assessment</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Opportunity costs</subject><subject>Pharmacoeconomics and Health Outcomes</subject><subject>Policy Making</subject><subject>Price regulations</subject><subject>Pricing policies</subject><subject>Public Health</subject><subject>Public Policy</subject><subject>Quality of Life Research</subject><subject>Review</subject><subject>Review Article</subject><subject>Thailand</subject><issn>1175-5652</issn><issn>1179-1896</issn><issn>1179-1896</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>7TQ</sourceid><recordid>eNp9UU1v3SAQRFGjJk37B3KokHrphQYw2NBLFT2lTaVIfYfk0BPCsH52xDMp2JHy74vz0nwdemGRdnZmdgehY0a_MEqbkywol4pQLgilmlIi99AhY40mTOn6zf1fEllLfoDe5XxNKa9rLd6ig0ppLYXmh-j3VQYcO7yKeSJnXQduGm5hhJzxZZ8g9zH4jIcRn4MNU-9sArye2zA4vI7lvfuK1ylu0jJgR49XvQ0Bxg3k92i_syHDh4d6hK6-n12uzsnFrx8_V6cXxBUXExHMMy-40pUEBb4VjlqpnJBWFbccRNN6WTmhavBNW7eSe9p1rKVaMV3RpjpC33a8N3O7Be9gnJIN5iYNW5vuTLSDedkZh95s4q1hTDTlbLIwfH5gSPHPDHky2yE7CMGOEOdsiopmDa_0IvbpFfQ6zmks-5mKMaXkskhB8R3KpZhzgu7RDaNmic7sojMlOnMfnVlcfHy-x-PIv6wKoNoBcmmVC6cn7f_Q_gV5WqRP</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Espinosa, Oscar</creator><creator>Rodríguez-Lesmes, Paul</creator><creator>Romano, Giancarlo</creator><creator>Orozco, Esteban</creator><creator>Basto, Sergio</creator><creator>Ávila, Diego</creator><creator>Mesa, Lorena</creator><creator>Enríquez, Hernán</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>4T-</scope><scope>7TQ</scope><scope>DHY</scope><scope>DON</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4893-0509</orcidid><orcidid>https://orcid.org/0000-0003-1058-3062</orcidid></search><sort><creationdate>20241101</creationdate><title>Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges</title><author>Espinosa, Oscar ; Rodríguez-Lesmes, Paul ; Romano, Giancarlo ; Orozco, Esteban ; Basto, Sergio ; Ávila, Diego ; Mesa, Lorena ; Enríquez, Hernán</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-41d1d428935e8edb4c0a58c45a82662e47bd53c486ed7b6b52d0ff1b098193073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Clinical decision making</topic><topic>Clinical outcomes</topic><topic>Comparative analysis</topic><topic>Cost analysis</topic><topic>Cost-Benefit Analysis</topic><topic>Costs</topic><topic>Decision making</topic><topic>Effectiveness</topic><topic>GDP</topic><topic>Gross Domestic Product</topic><topic>Health Administration</topic><topic>Health care expenditures</topic><topic>Health care policy</topic><topic>Health disparities</topic><topic>Health Economics</topic><topic>Health policy</topic><topic>Health Policy - economics</topic><topic>Health technology assessment</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Opportunity costs</topic><topic>Pharmacoeconomics and Health Outcomes</topic><topic>Policy Making</topic><topic>Price regulations</topic><topic>Pricing policies</topic><topic>Public Health</topic><topic>Public Policy</topic><topic>Quality of Life Research</topic><topic>Review</topic><topic>Review Article</topic><topic>Thailand</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Espinosa, Oscar</creatorcontrib><creatorcontrib>Rodríguez-Lesmes, Paul</creatorcontrib><creatorcontrib>Romano, Giancarlo</creatorcontrib><creatorcontrib>Orozco, Esteban</creatorcontrib><creatorcontrib>Basto, Sergio</creatorcontrib><creatorcontrib>Ávila, Diego</creatorcontrib><creatorcontrib>Mesa, Lorena</creatorcontrib><creatorcontrib>Enríquez, Hernán</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Docstoc</collection><collection>PAIS Index</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Applied health economics and health policy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Espinosa, Oscar</au><au>Rodríguez-Lesmes, Paul</au><au>Romano, Giancarlo</au><au>Orozco, Esteban</au><au>Basto, Sergio</au><au>Ávila, Diego</au><au>Mesa, Lorena</au><au>Enríquez, Hernán</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges</atitle><jtitle>Applied health economics and health policy</jtitle><stitle>Appl Health Econ Health Policy</stitle><addtitle>Appl Health Econ Health Policy</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>22</volume><issue>6</issue><spage>797</spage><epage>804</epage><pages>797-804</pages><issn>1175-5652</issn><issn>1179-1896</issn><eissn>1179-1896</eissn><abstract>The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>38995492</pmid><doi>10.1007/s40258-024-00900-5</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4893-0509</orcidid><orcidid>https://orcid.org/0000-0003-1058-3062</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1175-5652
ispartof Applied health economics and health policy, 2024-11, Vol.22 (6), p.797-804
issn 1175-5652
1179-1896
1179-1896
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11470905
source MEDLINE; PAIS Index; SpringerNature Journals
subjects Clinical decision making
Clinical outcomes
Comparative analysis
Cost analysis
Cost-Benefit Analysis
Costs
Decision making
Effectiveness
GDP
Gross Domestic Product
Health Administration
Health care expenditures
Health care policy
Health disparities
Health Economics
Health policy
Health Policy - economics
Health technology assessment
Humans
Medicine
Medicine & Public Health
Opportunity costs
Pharmacoeconomics and Health Outcomes
Policy Making
Price regulations
Pricing policies
Public Health
Public Policy
Quality of Life Research
Review
Review Article
Thailand
title Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A37%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20Cost-Effectiveness%20Thresholds%20in%20Healthcare%20Public%20Policy:%20Progress%20and%20Challenges&rft.jtitle=Applied%20health%20economics%20and%20health%20policy&rft.au=Espinosa,%20Oscar&rft.date=2024-11-01&rft.volume=22&rft.issue=6&rft.spage=797&rft.epage=804&rft.pages=797-804&rft.issn=1175-5652&rft.eissn=1179-1896&rft_id=info:doi/10.1007/s40258-024-00900-5&rft_dat=%3Cproquest_pubme%3E3079172397%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3118852893&rft_id=info:pmid/38995492&rfr_iscdi=true